Factors influencing poor response to type 2 targeted therapies in severe asthma: a retrospective cohort study
A significant breakthrough has been made in treating severe asthma, with the recognition of various asthma phenotypes and an updated management guideline. Type 2 targeted therapies, such as benralizumab and om...
Source: BMC Pulmonary Medicine - Category: Respiratory Medicine Authors: Mona Al-Ahmad, Asmaa Ali and Ahmed Maher Tags: Research Source Type: research